Showing results (221-230 of 16,212) with videos related to

Sort By:
Pageof 1,622
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of antidepressant and anxiolytic drugs in neonatal meconium and maternal hairSimona Pichini, Laura Cortes, Emilia Marchei, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2015
Quantitation of a low level coeluting impurity present in a modified oligonucleotide by both LC-MS and NMRMarco Smith, Tony Beck
Journal of Pharmaceutical and Biomedical Analysis|October 4, 2015
Dereplication of antioxidant compounds in Bene (Pistacia atlantica subsp. mutica) hull using a multiplex approach of HPLC-DAD, LC-MS and (1)H NMR techniquesMitra Rezaie, Reza Farhoosh, Ngoc Pham, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2015
Mastering analytical challenges for the characterization of pentacyclic triterpene mono- and diesters of Calendula officinalis flowers by non-aqueous C30 HPLC and hyphenation with APCI-QTOF-MSChristoph Nicolaus, Adrian Sievers-Engler, Renato Murillo, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 9, 2015
Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studiesRenu Chadha, Alka Bali, Gulshan Bansal
Journal of Pharmaceutical and Biomedical Analysis|September 24, 2013
Characterization of the isomeric configuration and impurities of (Z)-endoxifen by 2D NMR, high resolution LC⬜MS, and quantitative HPLC analysisPhyllis Elkins, Donna Coleman, Jason Burgess, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2013
Rapid determination of alendronate to quality evaluation of tablets by high resolution ¹H NMR spectroscopyBaogang Xie, Aihong Liu, Xiuzhong Fang, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 13, 2013
Development of novel chiral capillary electrophoresis methods for the serotonin receptor (5-HT2A) antagonist MDL 100,907 (volinanserin) and for its key intermediate compoundKrisztina Németh, Roberta Palkó, Péter Kovács, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 25, 2012
Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterizationClaudia Garnero, Virginia Aiassa, Marcela Longhi
Journal of Pharmaceutical and Biomedical Analysis|February 28, 2012
Application of nanoLC-ESI-TOF-MS for the metabolomic analysis of phenolic compounds from extra-virgin olive oil in treated colon-cancer cellsS Fernández-Arroyo, A Gómez-Martínez, L Rocamora-Reverte, et al.
Pageof 1,622